Nuclear Medicine Communications · 2011 · 11 citations · 0 references
MedicineNuclear MedicineSurgeryDiagnostic Nuclear MedicineDiagnostic RadiologyEndocrine SurgeryHyperparathyroidism SurgeryMinimally Invasive ParathyroidectomyParathyroid DisordersParathyroid ImagingParathyroid SurgerySurgical Management Of HyperparathyroidismGamma ScintigraphyIntraoperative Parathyroid Hormone AssayMinimally Invasive Parathyroid SurgeryParathyroid Gland HistologyParathyroid Hormone AssessmentParathyroid PathologyPrimary Hyperparathyroidism ImagingRadioguided Parathyroid Surgery
AIM: To evaluate the efficacy of the γ probe, alone and in combination with other techniques, in primary hyperparathyroidism surgery, as well as its ability to distinguish between single-gland and multiple-gland diseases. MATERIALS AND METHODS: Sixty-three patients with primary hyperparathyroidism submitted to radioguided parathyroidectomy, with a minimum follow-up of 1 year, were included. A preoperatory scintigraphy with technetium-99m methoxyisobutylisonitrile was performed in all cases and the excised specimens were histopathologically examined. Intraoperative intact parathyroid hormone (ioPTHi) data were available for 59 patients. RESULTS: Sixty-three patients underwent radioguided parathyroidectomy: 30 minimally invasive radioguided parathyroidectomy, 18 unilateral, and 15 bilateral surgeries. A receiver operating characteristic curve analysis was carried out to distinguish between normal and pathological glands. Using a cut-off value of 1.15 for the γ-probe in-vivo index, we obtained 87% sensitivity, 95% specificity, and 97% positive predictive value (PPV). There were statistically significant differences among in-vivo indexes sorted by type of gland histology (Kruskall-Wallis; P=0.001). A receiver operating characteristic curve was again used to discriminate between single-gland and several-gland pathologies. For a cut-off of 1.51, we achieved 67% sensitivity, 87% specificity, and 95% PPV. CONCLUSION: Pathological glands can be detected by the γ probe (in-vivo index>1.15) with a PPV of 97%. Although an in-vivo index greater than 1.51 is suggestive of a solitary adenoma (PPV=95%), there are a significant number of cases (27%) with lower indexes, these would erroneously lead to an extended surgery in search of a multiglandulary disease. For this reason, the combined determination of the intraoperative intact parathyroid hormone is recommended to identify multiglandulary disease.